Free Newsletter
| Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today! |
BMS starts laying off workers
The ax is starting to fall at Bristol-Myers Squibb. The company has started notifying employees that they'll soon be out of a job. Details on how many jobs will be cut and which areas will feel the most pain are expected next Wednesday during Bristol's conference call with analysts.
Laid-off workers will get severance, plus help finding new jobs. Many of them are probably already looking, considering the fact that CEO James Cornelius (photo) has been talking layoffs since July. The conference call will be webcast for the public, in case anyone wants to hear the news firsthand.
- see the release about the webcast from BMS
- read the Post-Standard report
Related Articles:
BMS to unveil layoffs, manufacturing cuts. Report
Cornelius get big payday for BMS temp job. Report
Better times ahead for BMS? Report
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness


